Session Information
2010 Midyear Clinical Meeting
Click here to go to the previous page
Acetaminophen Poisoning: What's the FDA Thinking? How Would You Vote?
Track:
Education Sessions (CE)
Program Code: 263-L01
Date: Wednesday, December 8, 2010
Time: 2:00 PM to 4:00 PM EST
Location:
Room 210A, Level 2
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation Edward Krenzelok
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation- Describe risk assessment, pathophysiology, and clinical presentation of acetaminophen poisoning.
- Describe the use of antidotes for acetaminophen toxicity.
- Discuss controversies regarding existing evidence and FDA Advisory Committee recommendations.
- Discuss the FDA actions and recommendations on acetaminophen.
This session is a part of:
Handout Online
